A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML

Name: A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML
Published: 2018
License: Public Domain

Novartis Pharmaceuticals · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

acute-myeloid-leukemia

acute myeloid leukemia, midostaurin, pkc412, cytarabine, daunorubicin, combination treatment, flt3, acute myeloid leukemia (aml), acute myelogenous leukemia (aml), interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML

Related documents